Position in DYN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,845,334
+$2,945,765 QoQ
Shares Held
443,284
+16.5% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 245 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,364,122 across 562 Biotechnology names. DYN ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in DYN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,845,334 | 443,284 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,899,569 | 380,561 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $7,451,929 | 380,978 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,419,758 | 349,388 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,159,459 | 121,792 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,742,106 | 357,754 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,725,038 | 540,112 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,475,824 | 625,719 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,608,254 | 243,929 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,624,152 | 233,327 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,649,865 | 124,050 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $485,255 | 54,158 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $253,901 | 22,569 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $16,692 | 1,449 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $110,985 | 9,576 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $13,284 | 1,046 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,076 | 1,030 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $98,058 | 10,172 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,898 | 412 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $406 | 25 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $50,907 | 3,278 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $209,160 | 9,960 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||